Travere Therapeutics Inc (TVTX)
EBITDA Margin
-16.88%
Quarterly · Period ending:
TVTX EBITDA Margin
Latest reported-16.88%period ending
Latest reported-16.88%period ending
TVTX Quarterly EBITDA Margin (0.00% → -16.88%)
Quarterly ebitda margin
High-resolution chart · PNG
TVTX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -16.8843% | |
| -7.2406% | |
| -0.4873% | |
| 26.8429% | |
| 3.606% | |
| -31.2338% | |
| -60.7485% | |
| -64.8987% | |
| -104.2834% | |
| -297.4984% | |
| -163.9073% | |
| -202.003% | |
| -273.565% | |
| -152.6784% | |
| -95.8742% | |
| -266.9172% | |
| -103.1975% | |
| -136.7624% | |
| -70.6563% | |
| -33.4579% | |
| -50.3341% | |
| -88.9299% | |
| -217.1253% | |
| -22.1357% | |
| -32.0421% | |
| -15.9622% | |
| -43.5615% | |
| -61.0506% | |
| -64.8086% | |
| -77.862% | |
| 5.6864% | |
| -114.8971% | |
| -41.8995% | |
| -34.9787% | |
| -14.5506% | |
| -35.5404% | |
| -25.1521% | |
| -25.0982% | |
| -20.5085% | |
| -76.4531% | |
| -14.4967% | |
| -4.9814% | |
| -121.7275% | |
| -32.8299% | |
| 0% | |
| -39.8675% | |
| -77.6642% | |
| -239.7652% | |
| -937.9133% | |
| -78,618.2151% | |
| -5,792.4405% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |